Follow BNTX's trial news. Pro members can get an alert when BioNTech files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 0.7% on Nov 3 while the S&P 500 rose 0.3%.
“The decreases were primarily driven by expected lower market demand for BioNTech’s COVID-19 vaccines.”
| Long-term trend | −3 |
| Latest filing | 6-K, Nov 3 |
BioNTech's mRNA cancer vaccine fails phase 3 test, significantly denting analysts' confidence
BNTX closed −7.1% that day on 1.5x normal volume.
Reports Tue Mar 2, before the open
Fri May 14: Annual Shareholder MeetingDate confirmed.
EUR 7.7B in cash
No shelf registration or at-the-market program on file in the last three years.
CEO Ugur Sahin sold 63,209 shares on Oct 9, under a planned sale. 14 more insider trades this year.
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
BNTX is #185 of 281 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 185 |
Reports Tue Mar 2, before the open (in 112 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
A profit of €0.73 a share.
“The decreases were primarily driven by expected lower market demand for BioNTech’s COVID-19 vaccines.”
BNTX's results filing gives no sales by line in a table we read. Its annual report gives the year's, in About.
| Measure | Figure |
|---|---|
| Revenue | €1.70 |
“R&D expenses were mainly driven by higher expenses for the development of BioNTech’s late-stage immuno-oncology (“IO”) and antibody-drug conjugate (“ADC”) programs and impairment expenses related to intangible assets which are outside of BioNTech’s strategic focus.”
From its results filing (SEC filing · Nov 3)
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 3, 2026 | +2.4% | -0.7% | -0.0% |
| Aug 4, 2026 | -3.5% | -1.0% | +0.6% |
| May 5, 2026 | -3.6% | -3.9% | -6.0% |
RSI 42.8, MACD above signal, below both averages. Not scored.
Officers and directors with a Form 4 in the last 12 months.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
BNTX scores -3 today, which Breakaway calls Poor. It is #185 of 281 in Biotech by Quality Score, with 2 of 14 chart checks firing. Down 0.7% on Nov 3 while the S&P 500 rose 0.3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
BNTX scores -3 today, which Breakaway calls Poor (below zero). That is #185 of 281 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind BNTX's -3.
Reports Tue Mar 2, before the open, a date the company confirmed. BNTX closed higher after 0 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.